Wegovy vs Mounjaro: First-Time Patient Comparison Guide
What's Best Wegovy or Mounjaro for New Patients Starting Treatment?
When determining what's best between Wegovy or Mounjaro as your starter medication, understanding the fundamental differences helps inform your decision. Wegovy contains semaglutide, which works exclusively on GLP-1 receptors to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, a dual-action medication targeting both GIP and GLP-1 receptors, offering a different mechanism of action that some patients may respond to differently.
The starter experience differs significantly between both medications, particularly in dosing schedules and practical considerations. Wegovy follows a structured 16-week escalation beginning with 0.25mg for weeks 1-4, designed to minimise side effects whilst your body adjusts to the GLP-1 mechanism. Both medications require clinical assessment and ongoing prescriber support, which our GPhC-registered team (#9012878) provides throughout your treatment journey at EverydayMeds.
Wegovy Starter Dose Pricing and Bundle Options
Understanding the cost implications when deciding what's best between Wegovy or Mounjaro starts with transparent pricing for your initial doses. Wegovy's starter dose at 0.25mg costs £79.99 for weeks 1-4, with new customers applying code FIRST40 at checkout to reach this price. The Intro Duo bundle (0.25mg and 0.5mg pens) provides your first 8 weeks of treatment for £169.99, covering the critical adjustment period when side effects are most likely to occur.
For patients preferring a slower escalation approach, our Gentle Start Trio bundle includes two 0.25mg pens plus one 0.5mg pen for £269.99, allowing extended time at the lowest dose. Returning customers benefit from code DOSE25 at checkout, whilst all pricing includes prescriber review, clinical assessment, and next-day cold-chain delivery to ensure medication arrives in optimal condition.
Clinical Evidence: What's Best Wegovy or Mounjaro Based on Trials?
Clinical trial data provides insight when considering what's best between Wegovy or Mounjaro, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, with the SELECT trial demonstrating a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials showed different results in separate patient populations, making direct percentage comparisons inappropriate and potentially misleading. Both medications demonstrated efficacy in their respective clinical programmes, with individual patient response varying significantly based on factors including baseline BMI, adherence to lifestyle modifications, and individual metabolic factors that your prescriber can help evaluate.
How Wegovy Works: GLP-1 Mechanism for New Patients
Understanding Wegovy's mechanism helps clarify what's best between Wegovy or Mounjaro for your specific situation. Wegovy mimics GLP-1, a natural hormone released by your intestines after eating that signals fullness to your brain's appetite centres. This prescription-only medicine works by slowing gastric emptying, meaning food stays in your stomach longer, promoting sustained satiety between meals. The medication also reduces food cravings by acting directly on hypothalamic appetite control centres, which many patients notice within the first few weeks of treatment. Unlike stimulant-based weight management approaches, Wegovy works with your body's existing hormone pathways rather than artificially suppressing appetite through stimulation. This natural mechanism explains why the gradual dose escalation starting at 0.25mg is essential—your GLP-1 receptors need time to adjust to the enhanced signalling for optimal effectiveness and tolerability.
EverydayMeds Ordering Process for First-Time Patients
Beginning treatment when deciding what's best between Wegovy or Mounjaro starts with our streamlined 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring clinical suitability for your chosen medication before dispensing. Once approved, your starter dose ships via next-day delivery using specialised cold-chain packaging that maintains the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) provides ongoing support throughout your dose escalation journey, with automated reminders when it's time to progress to your next strength. All patients receive comprehensive injection technique guidance, side effect management advice, and direct access to our clinical team for questions during your first month of treatment.
Storage and Practical Considerations for Starter Doses
Practical factors often influence what's best between Wegovy or Mounjaro, particularly regarding storage and travel convenience for active patients. Wegovy pens remain stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides precise 0.25mg dosing with clear dose confirmation, essential for patients new to self-injection who need confidence in their dosing accuracy. Weekly injection timing offers flexibility—you can inject any day of the week, though maintaining the same day helps establish routine during your starter phase. Your starter dose arrives pre-filled and ready to use, with each pen containing 4 doses of 0.25mg, eliminating any measurement concerns whilst you develop injection confidence during weeks 1-4.
What's Best Wegovy or Mounjaro: Starter Dose Tolerance and Adjustment
Patient experience during the starter phase often determines long-term treatment success, making the choice between Wegovy or Mounjaro particularly important for sensitive individuals. Wegovy's 0.25mg starter dose represents approximately 12% of the final maintenance dose, allowing gradual receptor adaptation that typically minimises gastrointestinal side effects like nausea or stomach discomfort. The 4-week duration at this lowest dose provides sufficient time for your body to adjust to enhanced GLP-1 signalling before progressing to 0.5mg in weeks 5-8.
Some patients benefit from extended time at the starter dose, which our Gentle Start Trio bundle accommodates with two 0.25mg pens for up to 8 weeks at the lowest strength. This approach particularly suits patients with sensitive stomachs, those taking multiple medications, or individuals preferring conservative dose escalation under close prescriber supervision available through our ongoing clinical support.
Making Your Decision: Wegovy Starter Support at EverydayMeds
Your final decision about what's best between Wegovy or Mounjaro benefits from professional guidance combined with transparent pricing and reliable supply. EverydayMeds provides both medications with identical clinical assessment standards, prescriber review processes, and cold-chain delivery protocols ensuring you receive optimal treatment regardless of your choice. Our starter dose pricing at £79.99 for Wegovy 0.25mg includes comprehensive support during your critical first month, when questions about injection technique, side effect management, and dose timing are most common. Use code FIRST40 at checkout for new patients, or DOSE25 for returning customers, with all orders processed through our secure clinical pathway. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns best with your medical history, lifestyle requirements, and weight management goals. Start your assessment today at https://everydaymeds.co.uk/products/wegovy-0-25mg for personalised clinical evaluation and next-day delivery of your chosen starter dose.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
